Yotam Reisner
Profile
Yotam Reisner is the founder of CorAssist Cardiovascular Ltd.
founded in 2003.
He previously worked as a Director-Pre Clinical Research at Enopace Biomedical Ltd., Manager-Cardiovascular Research at Itamar Medical Ltd., and Vice President-Clinical Affairs at Nephera Ltd.
Dr. Reisner holds a doctorate degree from Technion-Israel Institute of Technology.
Former positions of Yotam Reisner
Companies | Position | End |
---|---|---|
ITAMAR MEDICAL LTD. | Corporate Officer/Principal | - |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Corporate Officer/Principal | - |
Nephera Ltd.
Nephera Ltd. Medical SpecialtiesHealth Technology Nephera Ltd. develops products to protect the kidneys via neuro-hormonal modulation. Its technology is based on electrical stimulation of the urinary bladder in order to improve renal function using natural mechanisms. The firm's product RenaSense, which is a medical device that improves and maintains kidney functionality in patients suffering from decompensate heart failure. The company was founded by Gill Bar-Yoseph and Yair Feld in 2008 and is headquartered in Caesarea, Israel. | Chief Tech/Sci/R&D Officer | - |
CorAssist Cardiovascular Ltd.
CorAssist Cardiovascular Ltd. Medical SpecialtiesHealth Technology CorAssist Cardiovascular Ltd. develops therapeutic products for treating diastolic heart failure. Its proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. The firm’s product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The company was founded by Yair Feld, Yotam Reisner and Shay Dubi in 2003 and is headquartered in Haifa, Israel. | Founder | - |
Training of Yotam Reisner
Technion-Israel Institute of Technology | Doctorate Degree |
Experiences
Positions held
Linked companies
Private companies | 4 |
---|---|
CorAssist Cardiovascular Ltd.
CorAssist Cardiovascular Ltd. Medical SpecialtiesHealth Technology CorAssist Cardiovascular Ltd. develops therapeutic products for treating diastolic heart failure. Its proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. The firm’s product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The company was founded by Yair Feld, Yotam Reisner and Shay Dubi in 2003 and is headquartered in Haifa, Israel. | Health Technology |
Enopace Biomedical Ltd.
Enopace Biomedical Ltd. Medical SpecialtiesHealth Technology Enopace Biomedical Ltd. develops medical devices to treat heart failure patients. The firm's technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload and improves the systolic/diastolic ratio. The company was by Yossi Gross and Amir Dagan in 2008 and is headquartered in Caesarea, Israel. | Health Technology |
Nephera Ltd.
Nephera Ltd. Medical SpecialtiesHealth Technology Nephera Ltd. develops products to protect the kidneys via neuro-hormonal modulation. Its technology is based on electrical stimulation of the urinary bladder in order to improve renal function using natural mechanisms. The firm's product RenaSense, which is a medical device that improves and maintains kidney functionality in patients suffering from decompensate heart failure. The company was founded by Gill Bar-Yoseph and Yair Feld in 2008 and is headquartered in Caesarea, Israel. | Health Technology |
Itamar Medical Ltd.
Itamar Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets the WatchPAT and EndoPAT products. The WatchPAT diagnoses sleep apnea, a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur in 1995 and is headquartered in Caesarea, Israel. | Electronic Technology |
- Stock Market
- Insiders
- Yotam Reisner